Professional Documents
Culture Documents
DRUG STUDY
CLASSIFICAT
ION/ CONTRA- ADVERSE NURSING
DRUG NAME INDICATION
MECHANISIM INDICATION EFFECTS RESPONSIBILITY
OF ACTION
- Stop drug and tell
BRAND CLASSIFICAT -Inflammation - Contraindecate Adverse effect: prescriber if skin
NAME: ION: and pruritus d in patients GU: Glycosuria infection, striae or
Corticosteroid Triamcinolone from hypersensitive atrophy occur
is in a class of corticosteroid- to drug or its Metabolic: - If antifungal or
medication responsive components Hyperglycemia antibiotic combined
GENERIC called dermatoses - Contraindecate with corticosteroid
NAME: corticosteroids. d in the Skin: burning, fails to provide
Triamcinolone -Infammation presence of pruritus, irritation, prompt
acetonide from oral fungal, viral, or dryness, erythema, improvement, stop
(Topical) lesions bacterial folliculitis, corticosteroid until
ACTION: infection of the hypertrichosis,hypo infection is
Unclear, -Triamcinolone mouth or throat pigmentation, controlled.
DOSAGE: Diffuses topical is used (paste) acneiform - Systemic
Apply thin film across cell to treat the - Drug isn’t for eruptions, perioral absorption is more
2-4 times membranes to itching, ophthalmic use. deratits, allergic likely with the use
daily(0.025%) form redness, - Prolonged contact dermatitis, of occlusive
or 2-3 times complexes dryness, corticosteroid maceration dressing, prolonged
daily(0.1%, with crusting, therapy may secondary infection, treatment, or
0.5%) cytoplasmic scaling, interfere with atrophy, striae, extensive body
receptor, inflammation, growth and miliaria with surface treatment.
ROUTE: showing anti- and discomfort development in occlusive dressings. - Monitor skin
Topical inflammatory, of various skin children. integrity
antipruritic, conditions, - Use cautious in Others: HPA axis - If used for long time
FREQUENCY: vasoconstrictiv including elderly patients suppression, and on large skin
3-4 times x day e, and psoriasis (a because of age- Crushing syndrome. areas, monitor
antiproliferative skin disease in related changes patient for HPA axis
activity. which red, in skin integrity suppression.
scaly patches and risk Side effect:
form on some associated with burning,
Reference: areas of the systemic itching, irritation,
body and absorption. stinging,
Wolters eczema (a redness, or
Kluwer(2020) skin disease drying of the skin
Nursing2020 that causes
Drug acne
the skin to be
Handbook. dry and itchy change in
and to skin color
sometimes
develop red, unwanted
scaly rashes) hair growth
tiny red
bumps or rash
around the
mouth
small white
or red bumps on
the skin